Pancreatic islet macroencapsulation: A new device for the evaluation of artificial membrane

Artificial Organs

Volumn 20, Issue 9, 1996, Pages 997-1007

  Jesser, Cathy ^a   Kessler, Laurence ^a,c   Lambert, Alain ^b   Belcourt, Alain ^a   Pinget, Michel ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

AN69; Artificial membrane; Device; Macroencapsulation; Pancreatic islet; Xenotransplantation

Indexed keywords

BIOCOMPATIBILITY; COLLAGEN;

AN69; ARTIFICIAL MEMBRANES; COLLAGEN GELS; MACRO-ENCAPSULATION; MORPHOLOGICAL ASPECTS; NEW DEVICES; PANCREATIC ISLET; PERITONEAL CAVITY; TEST MEMBRANES; XENOTRANSPLANTATION;

MEMBRANES;

INSULIN;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; ENCAPSULATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; TRANSPLANTATION;

EID: 0029782684     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04587.x     Document Type: Article

References (26)

1. Sullivan SJ, Maki T, Borland KM, Mahoney MD, Solomon BA, Muller TE, Monaco AP, Chick WL. Biohybrid artificial pancreas: Long term implantation studies in diabetic pancreatectomized dogs. Science 1991;252:718-21.
2. Fan MY, Lum WRZP, Fu XW, Levesque L, Tai IT, Sun AM. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 1990;39:519-22.
3. Altman JJ, Houlbert A, Callard P, McMillan P, Solomon BA, Rosen J, Galetti PM. Long term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas. Diabetes 1986; 35:625-33.
4. Zekorn T, Siebers U, Filip L, Mauer K, Schmitt U, Bretzel RG, Federlin K. Bioartificial pancreas: The use of different hollow fibers as a diffusion chamber. Transpl Proc 1989;21: 2748-50.
5. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994;343:950-2.
6. Chicheportiche D, Reach G. In vivo kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules. Diabetologia 1988;31:54-7.
7. Moussy F, Rouchette J, Reach G. In vivo evaluation of a bioartificial pancreas under various hemodynamic conditions. Artif Organs 1989;13:109-15.
8. Gin H, Dupuy B, Baquet A, Baquet Ch, Ducassou D. Lack of responsiveness to glucose of macroencapsulated islets of Langerhans after three weeks' implantation in the rat: Influence of the complement. J Macroencapsulation 1990;7: 341-6.
9. Siebers U, Sturm R, Renardy M, Planck H, Zschocke P, Bretzel RG, Zekorn T. Morphological studies of biocompatibility of artificial membranes for immunoisolated islet transplantation. Horm Metab Res 1990;25:206-8.
10. Pillarella MR, Zydney AL. The critical analysis of the effect of connective flow on solute transport and insulin release in a hollow fiber bioartificial pancreas. J Biomech Eng 1990; 112:220-8.
11. Lhommeau C, Kessler L, Toillon S, Pith T, Belcourt A, Finget M. Polyamide 4/6 membranes for the encapsulation of Langerhans islets: Preparation, physicochemical properties and biocompatibility studies. J Mat Science 1996; (in press).
12. Montesano R, Mouron P, Amherdt M, Orci L. Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet-like organoids. J Cell Biol 1983;97: 935-9.
13. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16:35-9.
14. Lake SP, Anderson J, Chamberlain J, Gardner SJ, Bell PRF, James RLK. Bovine serum albumin density gradient isolation of rat pancreatic islets. Transplantation 1987;43:805-8.
15. Hill RS, Young SK, Jacobs SA, Martinson LA, Johnson RC. Membrane encapsulated islets implanted in epididymal fat pads correct diabetes in rats. Cell Transplantation 1992;213: 168-70.
16. Zekorn T, Siebers U, Bretzel RG, Renardy M, Planck H, Zschocke P, Federlin K. Protection of islets of Langerhans from interleukin 1 toxicity by artificial membranes. Transplantation 1990;30:391-4.
17. Kessler L, Pinget M, Aprahamian M, Dejardin P, Damgé C. In vivo and in vitro studies of the properties of an artificial membrane for pancreatic islet encapsulation. Horm Metab Res 1991;23:312-7.
18. Lacy PE, Hegre OD, Gerasimidi-Vazeov A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991;254:1782-5.
19. Amory B, Mourmeaux JL, Remacle C. In vivo cytodifferentiation of perinatal rat islet cells within a tridimensional matrix of collagen. In vivo Cell Dev Biol 1988;24:91-9.
20. Pipeleers DG. The biosociology of pancreatic β cells. Diabetologia 1987;30:277-91.
21. Andujar MB, Melin M, Guerret S, Grimaud JA. Cell migration influences collagen gel contraction. J Submicrosc Cytol Pathol 1992;24:145-54.
22. Kessler L, Aprahamian M, Keipes M, Damgé C, Pinget M, Poinsol D. Diffusion properties of an artificial membrane used for Langerhans islets encapsulation: An in vivo test. Biomaterials 1992;13:44-9.
23. Weber CJ, Zabinsi S, Koschitzky T, Rajotte R, Wicker L, Peterson L, D'agati V, Reemtsma K. Microencapsulated dog and rat islet xenografts into streptozotocin-diabetic and NOD mice. Horm Metab Res 1990;25:219-21.
24. Colton CK. The engineering of xenogeneic islet transplantation by immunoisolation. Diabetes, Nutr Metab 1992;5: 145-9.
25. Ling Z, In't Veld PA, Pipeleers DG. Interaction of interleukin-1 with islet β-cells. Distinction between indirect, aspecific, cytotoxicity and direct specific functional suppression. Diabetes 1993;42:56-65.
26. Wiegand F, Krancke KD, Kolb-Bachofen V. Macrophage-generated nitric oxide as cytotoxic factor in destruction in alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes. Transplantation 1993; 56:1206-9.